Whitepaper: The impact of COVID-19 on neurological systems
Posted: 13 October 2020 | PerkinElmer | No comments yet
Neurological symptoms have been observed in COVID-19 patients. The link between SARS-CoV-2 and the CNS is critical to developing effective treatments
Neurological symptoms including neuroinflammation, encephalopathy, acute necrotizing (hemorrhagic) encephalopathy (ANE), and ischemic stroke have been observed in COVID-19 patients. Even individuals who are mostly asymptomatic have experienced a loss or attenuation of smell and taste, indicative of a peripheral nervous system (PNS) effect. Understanding the link between SARS-CoV-2 and the CNS is critical to developing effective treatments.
Related content from this organisation
- Global high-content screening market set to be worth $2.52bn by 2030
- Assays for protein degradation therapeutics to accelerate undruggable proteome discoveries
- Lab automation market set to increase at CAGR of seven percent
- Brochure: Biologics workflow solutions brochure
- Brochure: Viral research solutions
Related topics
Assays, Disease Research, Imaging, Screening
Related organisations
PerkinElmer
